🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsBuyer Beware⚠ Amino Asylum raided by FDA June 2025 — what worked for you?

⚠ Amino Asylum raided by FDA June 2025 — what worked for you?

Dr.RheumBOS Wed, Apr 16, 2025 at 1:02 PM 31 replies 1,707 viewsPage 1 of 7
This thread is more than 13 months old. Information may be outdated. Consider searching for more recent discussions.
Dr.RheumBOS
Member
567
2,345
Apr 2024
Boston, MA
Apr 16, 2025 at 1:02 PM#1

Read the primary source rather than the write-up and the two do not agree, so here is what is actually in it.

The pattern that distinguishes a bad batch from an exit is behaviour rather than product. A bad batch comes with communication, a reshipment offer and a batch number. An exit comes with slower replies, pressure toward less reversible payment methods, sudden discounting, and the same reassurance repeated without any new information. The product tells you less than the correspondence does.

Where I think it is weakest: the completion rate deserves as much attention as the headline, because a large effect among those who finished is a different claim from a large effect among those enrolled.

What I am trying to establish is what a vetting checklist should actually contain, as opposed to a list of things that are easy to fake. Tell me what I have not thought of.

Note on sourcing:
Figures above are from the primary publication rather than the press summary. If a number here disagrees with one you have, post yours and we will work out which of us is reading a secondary source.
43 13pam_stl, wei_SG, cory_ATX and 40 others
Reply Quote Save Share Report
sarah.morrison
VIP Member
3,212
14,567
Jan 2024
California
Online
Apr 16, 2025 at 1:34 PM#2
Dr.RheumBOS said:
The pattern that distinguishes a bad batch from an exit is behaviour rather than product.

Agreeing with Dr.RheumBOS, and the qualification matters more than the agreement. The useful checklist is about verifiability rather than presentation. Independent test results commissioned by buyers rather than by the seller, consistency across multiple batches over time rather than one flattering report, a physical address and a company registration that resolve, batch and lot numbers on the actual labelling, and a shipping practice that matches what the material needs. Everything a good-looking website provides is cheap to fake; none of the items above are.

42 12roxy_nash, tony_orlando, Dr.NephBHM_UK and 39 others
Reply Quote Save Share Report
BenResearch_OR
Senior Member
2,456
11,234
Dec 2023
Oregon
Apr 16, 2025 at 2:06 PM#3
Dr.RheumBOS said:
The pattern that distinguishes a bad batch from an exit is behaviour rather than product.

I disagree that testing history is decisive. It tells you what a supplier did when they were being watched. Continuity of behaviour under stress — a late shipment, a failed test, a complaint — is more predictive than any run of good results.

41 11Dr.NateNeph, PharmD_Rodriguez, julia.endo and 38 others
Reply Quote Save Share Report

Janoshik Analytical — Independent Testing

Trusted third-party HPLC & mass spectrometry analysis. Verify peptide purity with the lab the community relies on. Independent. Accurate. Transparent.

Verify Your Peptides

GL Biochem (Shanghai) Ltd. — Direct Manufacturer

Est. 1998. The synthesis house behind the vials you send for testing. ISO 9001 and cGMP certified, 1,500+ staff, batch-specific COA with every order.

Browse GL Biochem
VendorMark
Senior Member
3,456
14,567
Jan 2024
Texas
Online
Apr 16, 2025 at 2:38 PM#4

This one has a reasonably settled answer, so here it is. Prices dramatically below market are the strongest single signal, and the reason is arithmetic rather than suspicion. Synthesis, testing, and cold-chain shipping have floors. A price well under the floor means something was skipped, and the two things that get skipped are testing and content.

40 10Dr.PeteFamMed, claudia_zurich, nancy_portland and 37 others
Reply Quote Save Share Report
steph_laguna
Member
234
1,123
Nov 2024
Laguna Beach, CA
Apr 16, 2025 at 5:33 PM#5
sarah.morrison said:
The useful checklist is about verifiability rather than presentation.

Adding a me-too, because a thread of one person's experience is not much use.

39 9marco_milano, pam_columbus, nick_SD_fit and 36 others
Reply Quote Save Share Report
1237

Similar Threads

⚠ Peptide Sciences SHUT DOWN March 6, 2026 — what happened and what to do now8 replies
⚠ Amino Asylum raided by FDA June 2025 — warehouse seized6 replies
⚠ Swiss Chems FDA warning letter December 2024 — selling unapproved drugs6 replies
⚠ 50+ FDA warning letters sent to peptide vendors in 2025 — full list4 replies
⚠ PeptideMeter exposed: some vendors scoring E grade on basic peptides4 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register